Doctor profile · Federal record

Dr. Christin Rowe, P.A.-C.

Physician Assistant · Fairhope, AL

  • NPI 1730129479
  • Accepts Medicare
  • MIPS 86.9 / 100 · 2023
  • 25 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 3 locations .

NPPES Updated May 11, 2026
Primary practice
202 Rock Creek Pkwy
Fairhope, AL 365323349
(251) 928-3844
fax (251) 928-3353
Additional location
1620 N McKenzie St
Foley, AL 365352248
(251) 501-2240
Additional location
200 Rock Creek Pkwy
Fairhope, AL 365323349
Mailing address
801 York St
Manitowoc, WI 542204630

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
November 9, 2023
Year of graduation
2001 — 25 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
Alabama #PA-288

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1730129479. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,820
Distinct HCPCS
10
Medicare allowed
$215,313
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,934 361 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 935 748 $71
17000 Destruction of precancer skin growth, 1 growth 698 533 $43
11102 Biopsy of related skin growth, first growth 295 264 $71
17110 Destruction of skin growth, 1-14 growths 285 249 $87
99214 Established patient office or other outpatient visit, 30-39 minutes 232 207 $99
99212 Established patient office or other outpatient visit, 10-19 minutes 106 94 $44
99203 New patient office or other outpatient visit, 30-44 minutes 97 97 $88
11103 Biopsy of related skin growth, each additional growth 37 32 $39
17004 Destruction of precancer skin growth, 15 or more growths 37 34 $131

In context: peer comparison

Among 6 peers in Fairhope Physician Assistant, average services per provider: 341. This provider delivers 14× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,089
Transactions
144
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 19 $649.81
Dermavant Sciences, INC. 23 $557.66
Sun Pharmaceutical Industries INC. 17 $495.57
Incyte Corporation 23 $405.37
Abbvie INC. 18 $328.27
Arcutis Biotherapeutics, INC. 6 $280.53
Novartis Pharmaceuticals Corporation 10 $219.20
E.R. Squibb & Sons, L.L.C. 6 $177.81
Organogenesis INC. 5 $144.11
Ucb, INC. 2 $141.80
Paratek Pharmaceuticals, INC. 1 $120.65
Ortho Dermatologics, A Division of Bausch Health US, LLC 4 $75.78
Pfizer INC. 4 $70.88
Regeneron Healthcare Solutions, INC. 3 $65.05
Genzyme Corporation 3 $62.17

By nature of payment

Food and Beverage
$3,920
Education
$168

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
870
Patients
500
Total drug cost
$408,594
Drug Type Claims Patients Total cost
Clobetasol Propionate Generic 251 169 $12,305
Doxycycline Hyclate Generic 115 39 $5,466
Triamcinolone Acetonide Generic 107 89 $1,455
Hydrocortisone Generic 65 53 $320
Ketoconazole Generic 53 28 $974
Fluorouracil Generic 51 44 $5,048
Humira(Cf) Pen (Adalimumab) Brand 36 0 $378,754
Hydroxyzine Hcl Generic 32 12 $257
Clindamycin Phosphate Generic 31 14 $984
Minocycline Hcl Generic 27 0 $482

Frequently asked questions

Auto-generated from federal data
What is Dr. Christin Rowe's medical specialty?
Dr. Christin Rowe practices Physician Assistant in Fairhope, AL.
Where does Dr. Christin Rowe practice?
Dr. Christin Rowe practices at 202 Rock Creek Pkwy, Fairhope, AL 365323349. Office phone: 2519283844.
What is Dr. Christin Rowe's NPI?
Dr. Christin Rowe's National Provider Identifier (NPI) is 1730129479, issued by NPPES.
Does Dr. Christin Rowe accept Medicare assignment?
Yes. Dr. Christin Rowe accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christin Rowe commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.